.

Dr Srikanth Bellary

Senior Lecturer

School of Life & Health Sciences
Aston University
Aston Triangle
Birmingham B4 7ET
UK

Room Number: MB710
Office Hours: Wed am/Thursdays
Tel: 0121 204 4145 

Email: s.bellary@aston.ac.uk 

Research Theme

 Chronic and Communicable Conditions

Research Centre 

Aston Research Centre for Healthy Ageing(ARCHA)

Dr Sri Bellary
Dr Sri Bellary
MBBS;MD,MRCP (UK)

Senior Lecturer, Aston Research Centre  for Healthy Ageing (ARCHA)
School of Life and Health Sciences

Consultant Physician and Clinical Director
Diabetes and Endocrinology
Heart Of England NHS Foundation Trust, Birmingham,UK

  • Epidemiology of Diabetes

  • Metabolic Regulation of Ageing

  • New therapies for Type 2 diabetes

Member of  Diabetes UK
Member of Royal College of Physicians Edinburgh,UK
Member – South Asian Health Foundation,UK

BOOK CHAPTERS 

1. Bellary S, Barnet AH. (2009)
Genetics studies in South Asians. 
Diabetes UK and South Asian Health Foundation recommendations on diabetes research priorities for British South Asians. 21-26 .ISBN 978-1-899288-88-5. 

2.Bellary S, Vora J, Barnett AH. (2009)
Diabetic Nephropathy. 
Diabetes UK and South Asian Health Foundation recommendations on diabetes research priorities for British South Asians.
2009.91-97 .ISBN 978-1-899288-88-5. 

3. Bellary S. (2009)
Should South Asians have lower targets? 
Clinical perspectives in Diabetes. (In press). 

4. Barnett AH, Dixon AN, Bellary S:(2005)
Diabetes and Cardiovascular disease in South Asians: challenges and solutions. 
Prevention, treatment and Rehabilitation of cardiovascular disease in South Asians.2005 61-83

RECENT PAPERS

1. Bellary S, O'Hare JP, Raymond NT, Mughal S, Hanif WM, Jones A, Kumar S, Barnett AH. (2010)
Premature cardiovascular events and mortality in south Asians with type 2 diabetes in the United Kingdom Asian Diabetes Study - effect of ethnicity on risk. 
Curr Med Res Opin.Aug;26(8):1873-9

 2. Rees SD, Britten AC, Bellary S, O'Hare JP, Kumar S, Barnett AH, Kelly MA (2009)
The promoter polymorphism -232C/G of the PCK1 gene is associated with type 2 diabetes in a UK-resident South Asian population.
BMC Med Genet. Sep 2;10:83

 3.Raymond NT, Varadhan L, Reynold DR, Bush K, Sankaranarayanan S, Bellary S et al. (2009)
Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with white Europeans in the community: a cross-sectional study. 
Diabetes Care Mar; 32(3):410-5 

4. Bellary S, O’Hare JP, Raymond NT, Gumber A, Mughal S, Szczepura A, Kumar S, Barnett AH; UKADS study Group.(2008)
Enhanced diabetes care to patients of south Asian ethnic origin (the United Kingdom Asian Diabetes Study): a cluster randomized controlled trial. 
Lancet   May 24:371(9626):1769-76 

5. Bellary S, Barnett AH. (2007)
Diabetes and cardiovascular disease in South Asians. 
Diabetes and Primary Care.   

6. Rees SD, Bellary S, Britten AC, O’Hare JP, Kumar S, Barnett AH, Kelly MA. (2008)
Common variants of the TCF7L2 gene are associated with increased risk of  diabetes in a UK based South Asian population. BMC Med Genet, Feb  21;9:8  

7. Bellary S, Barnett A H. (2007)
Selection and Education of patients for Inhaled insulin. 
Current Diabetes Reports  7:363-368 

8. Barnett A H, Bellary S. (2007)
Inhaled Human Insulin (Exubera): Clinical profile and patient considerations. 
Vasc. Health Risk Manage. 3(1): 83-91

9. Varma Chittari M, Bush K, Bellary S, Kumar S, Barnett AH, O’Hare JP. (2007)
Microvascular and cardiovascular disease in the South Asians: the emerging challenge. 
Pract Diab Int.   24(6):328-332

10. Bellary S, Barnett A H. (2006)
Inhaled Insulin (Exubera): Combining efficacy and convenience. Diab Vasc  Disease Res.Dec, 3(3):179-85  

11.Barnett AH, Dixon AN, Bellary S, Hanif MW,O’Hare JP, Raymond NT, Kumar S. (2006)
Diabetes and cardiovascular risk in the UK south Asian community.
Diabetologia. Oct;49(10):2234-46

12. Bellary S, Barnett AH:(2006)
Inhaled insulin: new technology, new possibilities. 
Int J Clin Pract. June  ,60,6,728-734

13.Bellary S, Barnett AH.(2006)
Inhaled insulin:Overcoming barriers in insulin therapy? 
The British Journal of Diabetes and vascular disease
May/June  Vol 6(3) 103-108

14.Barnett AH, Bellary S: (2006)
Novel metabolic drugs for the management of Diabetes. 
Pract. Diab Int. April  Vol.23 129-134

15. Bellary S, Barnett AH: (2006)
Needle free insulin: from dreams to reality. 
Pract. Diab Int. Mar. Vol.23 (2) 47-48

16. Bellary S, Barnett AH: (2005)
Exubera inhaled insulin in Type1 and diabetes.
Future prescriber Vol 6(3) 2005.

17.Bellary S, Bain SC: (2005)
Bicarbonate treatment in patients with diabetic ketoacidosis’. Practical Diabetes International-September  Vol.22(7) 260a

18. Bellary S, Anwar AJ, Harvey T C (2003)
The ‘Charcot Foot’.
The Lancet- Apr 5;361(9364):1225

19.Bellary S (2002)
Exercise consultation in Diabetes.
Diabetic Medicine. Oct;19(10):886

 

Dr S Bellary/Aston University/Last updated Jan 2014

Employable Graduates; Exploitable Research